Patients with COVID-19 had significantly higher CSF concentrations of neopterin, β2M, interleukin (IL) 2, IL-6, IL-10, and tumor necrosis factor α (TNF-α) compared with controls (Table 2 and Figure 2). This evidence concerns the gene B2M and COVID-19.